Investigating the Use of Gastroprotectants as a Means of Preventing Iatrogenic Gastrointestinal Signs Associated With Immunosuppressive Corticosteroid Therapy. A Retrospective Study

Adam Swallow BVSc, MRCVS1*

1University of Cambridge, The Old Schools, Trinity Ln, Cambridge, CB2 1TN
* (adamswallow26@gmail.com)


Vol 2, Issue 3 (2017)

Published: 20 Sep 2017


Background: Gastroprotectants are commonly prescribed in patients receiving immunosuppressive therapy with glucocorticoids. Presently, there is limited evidence to support such use of gastroprotectants.

Gastroprotectants are commonly prescribed in patients receiving immunosuppressive therapy with glucocorticoids. Presently, there is limited evidence to support such use of gastroprotectants. The objective of this study was to establish if the prophylactic use of gastroprotectants was associated with a reduced incidence of gastrointestinal signs in dogs receiving immunosuppressive doses of glucocorticoids, compared to not receiving prophylactic gastroprotectants.

Find out more about Adam.



Comments:



Open Access